Literature DB >> 24681487

Loss of the m-AAA protease subunit AFG₃L₂ causes mitochondrial transport defects and tau hyperphosphorylation.

Arun Kumar Kondadi1, Shuaiyu Wang, Sara Montagner, Nikolay Kladt, Anne Korwitz, Paola Martinelli, David Herholz, Michael J Baker, Astrid C Schauss, Thomas Langer, Elena I Rugarli.   

Abstract

The m-AAA protease subunit AFG₃L₂ is involved in degradation and processing of substrates in the inner mitochondrial membrane. Mutations in AFG₃L₂ are associated with spinocerebellar ataxia SCA28 in humans and impair axonal development and neuronal survival in mice. The loss of AFG₃L₂ causes fragmentation of the mitochondrial network. However, the pathogenic mechanism of neurodegeneration in the absence of AFG₃L₂ is still unclear. Here, we show that depletion of AFG₃L₂ leads to a specific defect of anterograde transport of mitochondria in murine cortical neurons. We observe similar transport deficiencies upon loss of AFG₃L₂ in OMA1-deficient neurons, indicating that they are not caused by OMA1-mediated degradation of the dynamin-like GTPase OPA1 and inhibition of mitochondrial fusion. Treatment of neurons with antioxidants, such as N-acetylcysteine or vitamin E, or decreasing tau levels in axons restored mitochondrial transport in AFG₃L₂-depleted neurons. Consistently, tau hyperphosphorylation and activation of ERK kinases are detected in mouse neurons postnatally deleted for Afg3l2. We propose that reactive oxygen species signaling leads to cytoskeletal modifications that impair mitochondrial transport in neurons lacking AFG₃L₂.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24681487      PMCID: PMC4193934          DOI: 10.1002/embj.201387009

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

Review 1.  Signal transduction cascades associated with oxidative stress in Alzheimer's disease.

Authors:  Robert B Petersen; Akihiko Nunomura; Hyoung-gon Lee; Gemma Casadesus; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2007-05       Impact factor: 4.472

2.  Regulation of mitochondrial morphology through proteolytic cleavage of OPA1.

Authors:  Naotada Ishihara; Yuu Fujita; Toshihiko Oka; Katsuyoshi Mihara
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

3.  Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology.

Authors:  Stéphane Duvezin-Caubet; Ravi Jagasia; Johannes Wagener; Sabine Hofmann; Aleksandra Trifunovic; Anna Hansson; Anne Chomyn; Matthias F Bauer; Giuseppe Attardi; Nils-Göran Larsson; Walter Neupert; Andreas S Reichert
Journal:  J Biol Chem       Date:  2006-09-26       Impact factor: 5.157

4.  Conserved actin cysteine residues are oxidative stress sensors that can regulate cell death in yeast.

Authors:  Michelle E Farah; David C Amberg
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

5.  Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1.

Authors:  Edda Thies; Eva-Maria Mandelkow
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

6.  Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons.

Authors:  Myriam Escobar-Khondiker; Matthias Höllerhage; Marie-Paule Muriel; Pierre Champy; Antoine Bach; Christel Depienne; Gesine Respondek; Elizabeth S Yamada; Annie Lannuzel; Takao Yagi; Etienne C Hirsch; Wolfgang H Oertel; Ralf Jacob; Patrick P Michel; Merle Ruberg; Günter U Höglinger
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

7.  Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia.

Authors:  Mirko Koppen; Metodi D Metodiev; Giorgio Casari; Elena I Rugarli; Thomas Langer
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

8.  The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria.

Authors:  Mark Nolden; Sarah Ehses; Mirko Koppen; Andrea Bernacchia; Elena I Rugarli; Thomas Langer
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

9.  Mitochondrial oxidative stress causes hyperphosphorylation of tau.

Authors:  Simon Melov; Paul A Adlard; Karl Morten; Felicity Johnson; Tamara R Golden; Doug Hinerfeld; Birgit Schilling; Christine Mavros; Colin L Masters; Irene Volitakis; Qiao-Xin Li; Katrina Laughton; Alan Hubbard; Robert A Cherny; Brad Gibson; Ashley I Bush
Journal:  PLoS One       Date:  2007-06-20       Impact factor: 3.240

10.  Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease.

Authors:  A Ebneth; R Godemann; K Stamer; S Illenberger; B Trinczek; E Mandelkow
Journal:  J Cell Biol       Date:  1998-11-02       Impact factor: 10.539

View more
  32 in total

Review 1.  Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms.

Authors:  Jesse S Kerr; Bryan A Adriaanse; Nigel H Greig; Mark P Mattson; M Zameel Cader; Vilhelm A Bohr; Evandro F Fang
Journal:  Trends Neurosci       Date:  2017-02-09       Impact factor: 13.837

Review 2.  New roles for mitochondrial proteases in health, ageing and disease.

Authors:  Pedro M Quirós; Thomas Langer; Carlos López-Otín
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05-13       Impact factor: 94.444

Review 3.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

4.  YME1L degradation reduces mitochondrial proteolytic capacity during oxidative stress.

Authors:  T Kelly Rainbolt; Jaclyn M Saunders; R Luke Wiseman
Journal:  EMBO Rep       Date:  2014-11-27       Impact factor: 8.807

5.  Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.

Authors:  Cristina Puchades; Bojian Ding; Albert Song; R Luke Wiseman; Gabriel C Lander; Steven E Glynn
Journal:  Mol Cell       Date:  2019-07-18       Impact factor: 17.970

6.  Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.

Authors:  Jinsoo Seo; Oleg Kritskiy; L Ashley Watson; Scarlett J Barker; Dilip Dey; Waseem K Raja; Yuan-Ta Lin; Tak Ko; Sukhee Cho; Jay Penney; M Catarina Silva; Steven D Sheridan; Diane Lucente; James F Gusella; Bradford C Dickerson; Stephen J Haggarty; Li-Huei Tsai
Journal:  J Neurosci       Date:  2017-09-14       Impact factor: 6.167

Review 7.  Consequences of inner mitochondrial membrane protein misfolding.

Authors:  Liam P Coyne; Xin Jie Chen
Journal:  Mitochondrion       Date:  2019-06-10       Impact factor: 4.160

Review 8.  mPOS is a novel mitochondrial trigger of cell death - implications for neurodegeneration.

Authors:  Liam P Coyne; Xin Jie Chen
Journal:  FEBS Lett       Date:  2017-11-14       Impact factor: 4.124

Review 9.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

Review 10.  Mitochondrial Quality Control Proteases in Neuronal Welfare.

Authors:  Roman M Levytskyy; Edward M Germany; Oleh Khalimonchuk
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.